We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

206 hedge funds and large institutions have $5.41B invested in Adaptive Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 96 increasing their positions, 43 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

281% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $5.3M

123% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 43

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

11% more capital invested

Capital invested by funds: $4.89B → $5.41B (+$523M)

5% more funds holding

Funds holding: 196 → 206 (+10)

2.4% more ownership

Funds ownership: 79.63% → 82.03% (+2.4%)

Holders
206
Holders Change
+10
Holders Change %
+5.1%
% of All Funds
4.16%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
39
Increased
96
Reduced
43
Closed
28
Calls
$20.2M
Puts
$5.3M
Net Calls
+$14.9M
Net Calls Change
+$7.88M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$59.9M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$46.9M
3
Norges Bank
Norges Bank
Norway
+$36.1M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$30M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.4M

Top Sellers

1
MCMC
Matrix Capital Management Company
New Hampshire
-$84.1M
2
HM
HealthCor Management
New York
-$16.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.4M
4
BlackRock
BlackRock
New York
-$12.8M
5
RSWM
Robertson Stephens Wealth Management
California
-$8.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$1.63B – – –
MCMC
2
Matrix Capital Management Company
New Hampshire
$638M -$84.1M -2,000,000 -13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$344M +$59.9M +1,424,673 +25%
BlackRock
4
BlackRock
New York
$258M -$12.8M -303,696 -5%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$187M +$46.9M +1,117,025 +41%
Massachusetts Financial Services
6
Massachusetts Financial Services
Massachusetts
$144M +$30M +713,320 +32%
GGHC
7
Gilder Gagnon Howe & Co
New York
$117M -$2.44M -57,990 -2%
Artisan Partners
8
Artisan Partners
Wisconsin
$99.9M -$706K -16,796 -0.8%
Neuberger Berman Group
9
Neuberger Berman Group
New York
$89.9M +$5.24M +124,605 +7%
SIG
10
Senator Investment Group
New York
$85.1M +$4.2M +100,000 +6%
Capital International Investors
11
Capital International Investors
California
$84.1M +$4.49M +106,846 +7%
TCM
12
TimesSquare Capital Management
New York
$70.5M -$5.3M -126,027 -8%
JP Morgan Chase
13
JP Morgan Chase
New York
$68.1M +$22.6M +538,418 +61%
Invesco
14
Invesco
Georgia
$61.7M +$1.63M +38,792 +3%
Goldman Sachs
15
Goldman Sachs
New York
$60.9M +$5.1M +121,232 +11%
TM
16
Tiger Management
New York
$54.2M – – –
Wells Fargo
17
Wells Fargo
California
$53.6M +$8.06M +191,746 +21%
ZCI
18
Zevenbergen Capital Investments
Washington
$48.3M +$9.04M +215,049 +28%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$47.7M +$18.7M +444,678 +83%
Fidelity Investments
20
Fidelity Investments
Massachusetts
$47.6M +$25.4M +603,311 +161%
American Century Companies
21
American Century Companies
Missouri
$46.1M +$6.21M +147,714 +18%
Norges Bank
22
Norges Bank
Norway
$45M +$36.1M +859,492 +1,297%
State Street
23
State Street
Massachusetts
$44.8M +$4.51M +107,210 +13%
AIM
24
ARK Investment Management
Florida
$43M +$24.2M +575,584 +186%
SPPAM
25
Summit Partners Public Asset Management
Massachusetts
$40.8M +$24.8M +589,563 +236%
1
2 3 4 5

ADPT Hedge Fund Activity: Q3 2020 in Review

206 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2020, worth a combined $5.41B — up 11% from $4.89B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ADPT positions and 28 closed out — a net gain of 11 holders — while 96 added to existing stakes and 43 trimmed.

The largest buyer was Vanguard Group, adding an estimated $59.9M. The largest seller was Matrix Capital Management Company, cutting an estimated $84.1M.

  • 206 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2020, up from 196 in Q2 2020.
  • Funds reported $5.41B of Adaptive Biotechnologies stock for Q3 2020, up 11% quarter-over-quarter.
  • 39 funds opened new Adaptive Biotechnologies positions in Q3 2020 and 28 closed out, a net change of +11 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2020 was Vanguard Group, an estimated $59.9M added.
  • The largest Adaptive Biotechnologies seller in Q3 2020 was Matrix Capital Management Company, an estimated $84.1M sold.

Based on aggregated 13F filings for Q3 2020.